Related by context. All words. (Click for frequent words.) 66 Euronext Amsterdam GLPGA 66 enhance ApoA 66 histone deacetylases HDAC 66 purinergic receptors P#X# 65 body AVI antiviral 65 uses NEUGENE antisense 65 regulate therapeutically important 65 recombinant biopharmaceutical 65 DNA RNA Medicines 64 London AiM GLPG 64 MCSP respectively 64 HPV cervical dysplasia 64 oncolytic virus therapies 63 developing ACAPODENE 63 nucleoside tide 63 Receptors GPCRs 63 Inovio clinical 63 CDK cyclin dependent 63 rxRNA 63 skeletal sarcomere activators 63 HPV cervical cancer 63 R Rituximab Herceptin 62 Cytokinetics cardiovascular disease 62 agonistic human 62 cancer indications bafetinib 62 GVAX ® 62 HIV AIDS neuropathic pain 62 Telik logo TELINTRA 62 dismutase MPO myeloperoxidase GPx 62 gastro intestinal inflammation 62 included Raf kinase 62 selectively inhibit replication 62 Ligand proprietary 62 orally administered inhibitor 62 developing ostarine selective 62 CytRx oncology pipeline 61 novel antimitotic agent 61 AVI RNA based 61 Raptor preclinical 61 oncology infectious diseases 61 telomerase inhibitor drug 61 rheumatoid arthritis thrombocytopenia 61 histone methyltransferases HMTs 61 HCV polymerase 61 anthrax tuberculosis typhoid 61 CYT# potent vascular disrupting 61 ovarian cancer chronic hepatitis 61 HIV integrase inhibitors 61 reversible inhibitor 61 EGFR inhibitors VEGF inhibitors 61 potently inhibit 61 multiple sclerosis HIV integrase 61 5 lipoxygenase activating 61 XL# XL# XL# XL# 60 MSCRAMM R 60 inflammatory autoimmune diseases 60 Bifunctional Muscarinic Antagonist Beta2 60 CD# CEA 60 cytoskeleton enables 60 AAG geldanamycin analog 60 IMC #B 60 highly selective inhibitor 60 Veronate R 60 specific neuronal nicotinic 60 ASG 5ME dacetuzumab SGN 60 novel peptides 60 peptibody 60 preclinical compounds 60 visit www.dendreon.com 60 ARRY # 60 pharmacogenomic translational research 60 delta opioid receptor 60 PI3K/mTOR 60 kidney urologic 60 myasthenia gravis Huntington 60 P#X# antagonist 59 www.lexpharma.com 59 Pruvel TM 59 Selective Electrochemical Tumor Ablation 59 VEGFR2 inhibitor 59 Inc. www.micromet inc.com 59 HCV polymerase inhibitors 59 Qualified Person overseeing Lydian 59 R MSCRAMM 59 candidate CRLX# 59 HCD# [002] 59 RAS MAPK pathway 59 accumulate preferentially 59 NS5A 59 smallpox SIGA 59 Tekmira SNALP stable 59 non nucleoside polymerase 59 XL# anticancer compounds 59 5 HT6 59 Reports Preclinical Data 59 orally bioavailable mimics 59 AKIP ™ 59 PDE4 inhibitor 59 mda 7 59 ALN TTR 59 lintuzumab SGN 59 anthrax botulism tuberculosis typhoid 59 visit biotech.com 59 REGN# 59 DNA methyltransferase inhibitors 59 pralatrexate injection folate analogue 59 ALN PCS 59 sapacitabine CYC# 59 promising anticancer 59 visit http:/www.dendreon.com 59 sodium Injection 59 telomerase therapeutic 59 detection reagents 59 IMiDs ® 59 THR beta agonist 59 novel anti infective 58 neuronal nicotinic receptors NNRs 58 please visit http:/www.sunesis.com 58 non nucleoside inhibitor 58 novel therapeutic antibodies 58 NS5b 58 CFTR corrector 58 clinical trials SGN 58 molecular chaperone regulation 58 PORxin TM platforms 58 anthrax botulism typhoid 58 Kosan dependence 58 AVID elective 58 PNP inhibitor 58 diabetes irritable bowel 58 epothilone 58 non nucleoside HCV 58 system REG1 consists 58 Adnectin 58 protein kinase inhibitors 58 anionic backbone 58 MEK inhibitor 58 POSIDUR TM ELADUR TM 58 vaccine GRNVAC1 58 inhibit replication 58 adhesion molecule EpCAM expressing 58 specific chemokine receptors 58 Prodarsan R 58 CK # novel 58 RNA antagonists 58 nucleoside tide analogs 58 peptidic compound 58 IMPDH inhibitor 58 activate SIRT1 58 Parkinson disease monogenic diseases 58 systemic RNAi therapeutic 58 ATRA IV 58 Multiple Sclerosis Rheumatoid Arthritis 58 Cytokinetics unpartnered cardiovascular disease 58 CYP#A# CYP#D# 58 immune stimulatory 58 Protexia ® 57 solid tumors ZYBRESTAT 57 TÎ ² 4 57 IMiDs R 57 novel immunomodulatory 57 Solazed TM 57 drug conjugates ADCs 57 transthyretin TTR 57 SIX RO ROG 57 Epothilone D 57 CEA CD# Her2 57 generation URAT1 inhibitor 57 molecular therapeutics immunotherapies 57 novel emulsion formulation 57 MSCRAMM ® 57 dimebon latrepirdine 57 PORxin TM 57 JAK2 inhibitor 57 XL# XL# 57 MKC# MT 57 anti infective compounds 57 HIV maturation inhibition 57 omecamtiv mecarbil formerly 57 oral proteasome inhibitor 57 Alfacell proprietary ribonuclease 57 Ostabolin C TM 57 androgen receptor modulator 57 targeted radiotherapeutic 57 FirstLook pre feature 57 active AKT inhibitor 57 SinuNase ™ 57 immunotoxin 57 therapeutic peptide 57 GVAX cancer 57 DG# compounds targeting 57 Merck OSI Pharmaceuticals 57 oral NKTR 57 Pharmos pipeline 57 Aganocide ® 57 InterfeRx TM 57 isatoribine 57 novel peptide 57 pan histone deacetylase 57 Pruvel ™ 57 bioengineered novel 57 commercialize CorMedix drug 57 CORT # 57 Completes Patient Enrollment 57 include Altastaph TM 57 Ceragenin ™ 57 ZFP Therapeutics 57 Abbott Laboratories AstraZeneca 57 novel histone deacetylase 57 CB2 receptor selective 57 XOMA 3AB 57 alpha folate receptor 57 anti botulism antibody 57 Omacetaxine 57 product TNFerade TM 57 ZFNs clinical trials 57 novel L DOS# 57 ThermoDox ® clinical 56 NTDDS 56 oral nucleoside analogue 56 Cobalamin TM mediated 56 antiangiogenesis therapies 56 PDE4 modulators 56 JAK2 Inhibitor 56 Inc. Nasdaq IMGN 56 Presents Preclinical Data 56 proprietary MSCRAMM protein 56 cosmetic cosmeceutical products 56 catalytic antioxidant compounds 56 proteins peptides 56 photodynamic therapy dermatology 56 peripherally acting 56 Presents Preclinical 56 PI3K/Akt pathway inhibitor 56 Exelixis compounds 56 HGS# 56 Exherin 56 modulate ion channel 56 molecular imaging radiopharmaceuticals 56 humanized monoclonal antibodies 56 oral ghrelin agonist 56 cardiovascular disease neurodegenerative diseases 56 HCV RNA polymerase 56 oral prodrug 56 epigenetic enzymes 56 Fully Employed MBA 56 ALTROPANE R 56 subsidiaries visit http:/www.apricusbio.com 56 symbol AVXL 56 ADMET database 56 NexVas TM 56 rheumatoid arthritis inflammatory bowel 56 concomitant plasma glucose 56 REVIVE Diabetes 56 CCR9 antagonist 56 candidate Lovaxin C 56 TELINTRA R 56 Phase 2a clinical trials 56 Offering Pilates 56 mGluR5 negative 56 selective androgen receptor modulators 56 PEG SN# 56 siRNAs targeting 56 HGS ETR2 56 receptor inhibiting monoclonal 56 hypoxia activated prodrug 56 commercializing oxidized glutathione 56 MEK Inhibitor 56 Tarvacin Anti Cancer 56 biomarkers predictive 56 Aganocide 56 NexVas TM PR 56 adrenal steroid hormones 56 Maxy G# 56 oral picoplatin 56 Inc. Nasdaq OXGN 56 Genasense oblimersen sodium Injection 56 Nicotine Conjugate Vaccine 56 molecules peptides 56 Panzem R 56 Crofelemer budesonide foam 56 diagnostic molecular imaging 56 histone deacetylase inhibitor 56 NNRs 56 Budesonide foam crofelemer 56 HepDirect R 56 epithermal gold mineralized 56 inhibit oxidative stress 56 XP# XP# 56 Hsp# Inhibitor 56 including eniluracil ADH 56 Smac mimetics 56 visit www.mediasciences.com E 56 estrogen receptor beta agonist 56 Genentech sanofi aventis 56 Initiates Enrollment 56 antisense inhibitors 56 Pentad TM 56 PEGylated interferon 56 RELOVAIR ™ 55 include VALSTAR TM 55 candidate XP# 55 compound CMX# 55 HIV integrase inhibitor 55 Initiates Phase II 55 Pharmos proprietary 55 chimeric monoclonal antibody 55 basal cell carcinoma squamous 55 anticancer therapeutics 55 GATTEX ® 55 acid phosphatase PAP 55 Nanobody ® 55 fitball courses 55 next generation URAT1 55 Begins Dosing 55 visit www.sciclone.com 55 addition MethylGene preclinical 55 CCR5 mAb 55 TRIOLEX ™ 55 muscarinic receptor agonist 55 NNR Therapeutics selectively modulate 55 alvespimycin 55 Sapacitabine 55 human IgG1 monoclonal 55 NRTIs NNRTIs 55 Universal Pandemic Influenza 55 ART# 55 El Santuario gold 55 technology visit http:/www.genmab.com 55 TKB# 55 multi kinase inhibitor 55 seliciclib CYC# 55 staphylococcal vaccine 55 small molecule tyrosine 55 maturation inhibition 55 cortisol synthesis 55 Anticalins R 55 using ImmunoGen TAP 55 ENMD # 55 Aeolus Pharmaceuticals Announces 55 rotavirus shingles 55 TRANSDUR ™ 55 S#P# 55 osteo exercise 55 Epothilones 55 oral PTH 55 apricitabine ATC 55 Nasdaq RXII 55 TKM PLK1 55 cutaneous T 55 visit www.genmab.com 55 Tumour Vascular Disrupting Agent 55 please visit http:/www.vandapharma.com 55 Nuvelo Announces 55 GVAX R 55 pentadentate logo R 55 potently inhibited 55 forodesine 55 lead molecular radiotherapeutic 55 superior bioprocessing 55 selective inverse agonist 55 biologic therapeutics 55 optical biosensors 55 novel orally administered 55 synthetic retinoid 55 prostate cancer antigen prostatic 55 demonstrated anti amnesic 55 candidate REP# 55 highly selective endothelin 55 IMiDs ® compound 55 Nasdaq ENMD 55 VTAs 55 Phase 2b Clinical Trial 55 Children VFC 55 leading lipid nanoparticle 55 selective kinase inhibitor 55 HGS ETR1 mapatumumab 55 neuronal nicotinic receptor NNR 55 recombinant PSMA vaccine 55 please visit www.medefile.com 55 MorphoSys proprietary 55 refractory chronic lymphocytic 55 isoform selective 55 deposited preferentially 55 4SC AG ISIN DE# 55 TransVax ™ 55 melanocortin receptor 55 IAP inhibitor 55 molecular imaging radiopharmaceutical 55 Dyax phage display 55 HPN develops 55 Inotek Pharmaceuticals Corporation 55 carcinoid syndrome diabetes 55 romazarit 55 ErbB3 HER3 55 oral calcitonin licensed 55 Affilin ® 55 adrenergic regulation 55 proprietary phage display 55 Mali Mozambique 54 novel anticancer 54 Amigal TM 54 drug conjugate 54 ImmunoGen TAP technology 54 provinces Zhejiang Fujian 54 OMP #R# 54 intranasal insulin product 54 protein tyrosine phosphatase 1B 54 drug conjugate ADC 54 Therapeutic Competitors Companies 54 visit www.targanta.com 54 Panzem R NCD 54 PSMA ADC 54 ASG 5ME 54 Met receptor tyrosine 54 colorectal bladder 54 Antibody Drug Conjugate 54 proprietary BiTE ® 54 ELADUR ™ 54 please visit http:/www.atherogenics.com 54 Kinase Inhibitor 54 Initiates Clinical Trial 54 vinca alkaloid 54 histone deacetylase HDAC inhibitor 54 antimitotic 54 HDL Mimetic Peptide 54 WGU nursing 54 R#/MEM # 54 TRACON Pharmaceuticals 54 antibiotics antifungals 54 molecular biology genomics proteomics 54 budesonide MMX ® 54 sulfonylhydrazine class 54 EnVivo Pharmaceuticals 54 Genasense R oblimersen 54 EVIZON TM squalamine lactate 54 evaluating picoplatin 54 cytomegalovirus CMV HAE 54 Miraxion Amarin lead 54 lead Aganocide compound 54 PI3 K 54 Provectus Pharmaceuticals specializes 54 visit www.ad tech.com 54 Potelligent Technology 54 apoptosis inducer 54 oncology metabolic disorders 54 ViroChem 54 class anticancer quinolone 54 development peramivir neuraminidase 54 clinical trials dacetuzumab SGN 54 adecatumumab MT# 54 antibody MAb 54 aldehyde dehydrogenase ALDH2 deficiency 54 NU# direct 54 Anticalin 54 CYT# vascular disrupting 54 programs visit http:/www.bionovo.com 54 regenerative stem cell 54 Factor VIIa 54 Trofex 54 cholesteryl ester transfer 54 Sulonex TM 54 discussed NuroPro Power3 54 INxin TM 54 Quinamed R 54 FOLOTYN ® 54 Panzem NCD 54 protein receptors lectins 54 ALN HTT 54 Rigel R# 54 Naglazyme R 54 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 54 glucokinase activator 54 Nasdaq HALO biopharmaceutical 54 EHT AGN 54 U1 Adaptors 54 Hsp# inhibition 54 Engineering Thermodynamics 54 therapeutics diagnostics 54 Initiates Clinical 54 nicotinic alpha 7 54 behavioral neurobiology 54 molecular biomarker 54 reviving moribund credit 54 Pharma Merck Serono 54 anticoagulant reversing agent 54 evaluating tivozanib 54 hyaluronidase enzyme 54 drug conjugates 54 proteasome inhibitor 54 www.cellgenesys.com 54 Vascular Disrupting Agent 54 Ashrat Shafiq Mohammed 54 Tß4 54 SuperAntibody 54 triciribine phosphate monohydrate 54 oncolytic 54 TNFerade ™ 54 InterfeRx 54 developing adecatumumab 54 SAR# [002] 54 http:/www.sangamo.com 54 MTP inhibitor 54 drug pipeline TAFA# 54 RGB # 54 MAXY G# 54 Clinical Transfusion 54 VentiRx Pharmaceuticals 54 RNAi reagents 54 HUMIRA resembles 54 OvaRex R 54 anti amnesic 54 Nanobody R 54 Imetelstat 54 Nasdaq IDRA today 54 developing Zerenex ferric 54 Posiphen TM 54 delta isoform 54 antibiotics antidepressants antifungal 54 Additional BiTE antibodies 54 topical anti infectives 54 Vaxfectin ® 54 CCX# 54 TRIOLEX HE# APOPTONE HE# 54 Xcytrin R 54 investigational therapies 54 tubulin inhibitor 54 intravesical infusion therapy 54 treats acute lymphoblastic 54 small molecule glucokinase 54 peptides proteins 54 www.micromeminc.com 54 potent antiproliferative 54 Locked Nucleic Acid 54 Urocortin 2 54 Genasense ® oblimersen 54 histone deacetylase HDAC inhibitors 54 Stapled Peptide 54 preclinical 54 oral dihydropyrimidine dehydrogenase DPD 54 Angiocept 54 TWC MSS 54 imetelstat GRN#L 54 HQK 53 CB2 selective receptor agonist 53 Cephalon GlaxoSmithKline 53 Phase #b/#a clinical 53 siRNA sequences 53 Canvaxin TM 53 secretory phospholipase A2 53 IAP inhibitors 53 selectively inhibited 53 called maturation inhibitors 53 Elotuzumab 53 Maine Township MaineStreamers 53 FOLFOX6 chemotherapy regimen 53 FEPL 53 Visit www.BASInc.com 53 RNAi therapeutic targeting 53 RNAi Therapeutic 53 malignant mesothelioma Alfacell 53 M2 subunit 53 sodium glucose cotransporter 53 SIRT1 activators 53 Hsp# inhibitors 53 HEPLISAV TM hepatitis B 53 Tracheitis 53 Helen Mirren Robert Pattinson 53 highly prospective Deseado 53 CB2 selective 53 tivozanib AV 53 synthetic peptide containing 53 biotherapeutic drugs 53 mGluR2 NAM 53 include PLX IBD 53 Hematide ™ 53 Amgen discovers develops 53 immunology oncology 53 please visit www.tranzyme.com 53 apply Enhanze technology 53 siRNA therapeutic 53 generation HCV protease 53 fatty acid amide hydrolase 53 sodium glucose transporter 53 Elvitegravir 53 Micromet proprietary BiTE 53 ALN HPN 53 hepatitis C polymerase inhibitor 53 serious systemic Staphylococcal 53 Neo Kidney Augment ™ 53 Inc. NASDAQ TRGT 53 world safest multivalent 53 Presents Positive 53 targeting CD# 53 cMET 53 genomics proteomics biosensors 53 mertansine 53 MediGene focuses 53 XmAb ® 53 Aurora kinase inhibitor 53 CRACM 53 Arthritis Aquatic 53 Phase #/#a trial 53 albiglutide 53 proprietary BiTE R 53 candidate bevirimat PA 53 mGluR4 mGluR2 mGluR5 53 Cathepsin S 53 activin receptor type 53 Archexin 53 epigenetic therapies 53 Amgen Kyowa Hakko Kirin 53 neurology immunology 53 biochemical profiling 53 Homspera TM 53 developing TB4 53 infectious autoimmune 53 Personalized Immunotherapy 53 HCV nucleotide polymerase inhibitor 53 cyclophilin inhibitor 53 immunotherapeutic approaches 53 nitric oxide donating 53 nucleotide analog 53 anti secretory 53 virus AAV 53 ALN VSP 53 fusion enhancers 53 genomes metagenomics RNA 53 TRANSDUR ® 53 endosomal release 53 selective S#P# receptor agonist 53 dihydrofolate reductase DHFR 53 c Raf kinase 53 oral talactoferrin 53 personalized cellular immunotherapy 53 Ligand utilizes 53 kinase inhibitor 53 Blinatumomab 53 MEK inhibitors 53 Inc. www.chemaphor.com uses 53 PLX MS 53 http:/www.celgene.com 53 Fc fusion protein 53 AKT inhibitor 53 MKC# MKC# PP 53 Group Mineral PGM 53 Evoltra ® 53 IND enabling 53 dacetuzumab SGN 53 candidates bavituximab 53 BHT DNA 53 trastuzumab DM1 T DM1 53 selective androgen receptor modulator 53 developing calcitonin 53 BiTE R 53 proprietary biomaterials 53 HCV NS5B polymerase 53 therapeutic monoclonal antibody 53 evaluating satraplatin 53 nanobiotech 53 Azedra ™ 53 PHX# 53 AVI BioPharma Announces 53 Marqibo TM 53 preclinical toxicology 53 cyclophilin inhibitors 53 HCV protease 53 clinically validated targets 53 Faithfully Fit exercise 53 0 SHOTS OFF 53 Curaxin CBLC# 53 NovaBay Aganocide 53 Unidym licensing 53 Sudhir Agrawal D.Phil 53 manages Corex 53 HCV NS3 protease 53 orally bioavailable 53 IL-#/# 53 Hybridon 53 selectively inhibits 53 Phase IIb clinical trials 53 GLP toxicology studies 53 novel RNAi therapeutics 53 polymerase inhibitor 53 KinomeScan 53 trastuzumab Herceptin R 53 telomerase inhibitor 53 Predictive medicine 53 Triapine R 53 synthetic cannabinoid library 53 PDE7 53 EMCORE Photovoltaic segment 53 PRLX # 53 www.usa.canon.com kyosei 53 midstage clinical 52 polymerase inhibitors 52 taxane derivative 52 Quaker BioVentures invests 52 Aurora Kinase 52 Arthritis Foundation aquatic 52 www.keithley.com events semconfs 52 STTR grants 52 developing Zerenex TM 52 potent recombinant 52 TKM ApoB 52 A3 adenosine receptor 52 Alzheimer disease frontotemporal dementia 52 liposomal formulation 52 Virium 52 website www.celsion.com 52 deCODE AF TM 52 HuCNS SC ® 52 CD4 monoclonal antibody 52 INSPIRE Trial Phase III 52 AKIP TM 52 PLK1 SNALP 52 developing biomedical countermeasures 52 Prodarsan ® 52 LentiVector technology 52 PEGylated irinotecan 52 Cytogen marketed 52 discovery anddevelopment 52 inflammation metabolic disorders 52 therapeutic mAbs 52 siRNA therapeutics 52 apoptosis proteins 52 therapeutic monoclonal antibodies 52 immunotherapies 2A/Furin 52 protein kinase inhibitor 52 small molecule 52 Hepatitis C Virus HCV 52 cardio metabolic diseases 52 Annie Lennox Kelly Clarkson 52 website http:/www.celsion.com 52 Merck Serono Nycomed 52 indications Cytokinetics 52 please visit www.metabolon.com 52 volociximab 52 peptidic 52 IX XII 52 histone deacetylase HDAC 52 HuMax TAC 52 generation Hsp# inhibitor 52 nilotinib Tasigna ® 52 generation radiolabeled antibody 52 TM Aganocide 52 Bezielle 52 Monomoy implements customized 52 rxRNA compounds 52 Innovive Pharmaceuticals 52 microsystems MEMS 52 Empatic ™ 52 mGluR5 NAM 52 initiated Phase 1b 52 TELINTRA 52 NADPH oxidase inhibitors 52 ZFP TFs 52 beta secretase inhibitors 52 genomics bioinformatics 52 Nanobodies ® 52 Extending GestatioN 52 HGS ETR1 52 epothilones 52 erlotinib Tarceva ® 52 including Cobalamin TM 52 JAK1 52 targeting abnormally proliferating 52 investigational monoclonal antibody 52 Oral NKTR 52 MT#/MEDI-# 52 fungal infections malaria tuberculosis 52 MKC# 52 dAb 52 recombinant plasma 52 Hedgehog pathway inhibitor 52 nitric oxide donating prostaglandin 52 mechanistic biomarkers 52 Aganocide R 52 regenerative therapeutics 52 TLR7 agonist 52 markets Testim ® 52 Investigational Oral 52 prokinetic agent 52 NYFCC awarded 52 IMiDs 52 lexidronam injection 52 isoform selective inhibitors 52 hepatoprotective agent 52 anticancer compounds 52 R roscovitine 52 Phase 2a Trial 52 anti PlGF 52 investigational humanized monoclonal antibody 52 POTELLIGENT R 52 GRN# 52 SPP# [002] 52 MOR# 52 SPL# Gel vaginal microbicide 52 JAK inhibitors 52 please visit www.advaxis.com 52 Phase 1b clinical trials 52 LNP formulations 52 virus HCV protease inhibitor 52 Symadex 52 phosphatidylserine PS targeting 52 generation PNP inhibitor 52 topical antifungal product 52 ABL inhibitor 52 ongoing Phase IIIb 52 generation purine nucleoside 52 potentially treat nephropathic 52 selective angiogenic kinase inhibitor 52 CRTH2 52 Chimigen TM 52 maturation inhibitor 52 AIDS prophylaxis congestive 52 KSP inhibitor 52 selectively induce apoptosis 52 Sodium Sulfate Sodium Chloride 52 demonstrated antitumor activity 52 EGEN 52 non peptide macromolecular 52 GED prep 52 leading oral taxane 52 please visit www.middlebrookpharma.com 52 CARExpress Plus membership 52 Zemiva TM 52 NAMI Basics 52 stage antibody MT# 52 VitiGam 52 RDEA# potent 52 http:/www.memorypharma.com 52 Nanobody 52 NEUGENE R 52 DGAT1 inhibitors 52 candidate AQ4N 52 Cyclooxygenase Inhibiting Nitric Oxide 52 proprietary bioresorbable polymer 52 Selzentry Celsentri 52 commercialize lorcaserin 52 Luveris R Ovidrel R 52 Accelerated Intelligent 52 SECTA therapy 52 Pertuzumab 52 Shows Promise Against 52 proprietary PEGylation 52 Daclizumab 52 Insegia 52 2 methoxyestradiol 52 Merck Serono discovers develops 52 Ostarine ™ 52 Intellikine 52 HCV protease inhibitor 51 Curaxins 51 ionotropic glutamate receptor antagonists 51 CR# vcMMAE 51 docetaxel Taxotere R 51 www.vivus.com 51 HEART Literacy Adult 51 YOUR LOCAL ANIMAL SHELTER 51 Trofex TM 51 Nasulin ™ 51 HCV protease inhibitors 51 mitogen activated ERK kinase 51 sarcoma melanoma 51 novel topoisomerase 51 SMIP 51 BCR ABL tyrosine kinase 51 Through Glycoscience R 51 irreversible inhibitor 51 % Unconsolidated Commissions 51 www.holliseden.com 51 JVRS 51 MDR Gram negative 51 metaglidasen 51 maximally tolerated dose 51 Virulizin ® 51 TLR9 agonist 51 Actilon 51 Tesetaxel 51 snake tarantula 51 TRIOLEX HE# 51 AVI antisense 51 UltiMAb 51 Cloretazine ® 51 ribonucleotide reductase clinically validated 51 pan HDAC inhibitor 51 NAEYC accredited 51 diverse bioactive peptides 51 agents VDAs 51 oral Hsp# inhibitor 51 cleavable linker 51 Arno Therapeutics 51 immune modulating 51 SENIOR CENTER Programs 51 topically applied SEPA 51 hematological tumors 51 Oil Recovery Bypassed 51 www.polymedix.com 51 By JAMAAL ABDUL 51 OF THALIDOMIDE 51 HATHA YOGA FOR BEGINNERS 51 predictive toxicology 51 multicenter Phase III 51 HepeX B TM 51 Exelixis XL# 51 Adamis Viral Therapies 51 hepatitis C HCV 51 MultiStem ® 51 VVC Exploration Corporation 51 Aurora kinase 51 IKK epsilon 51 platinum chemotherapeutic 51 multiple sclerosis rheumatoid arthritis 51 VIBATIV ™ 51 PF # [002] 51 poly ADP ribose polymerase 51 IMC A# 51 GATTEX ™ 51 intracellular protein 51 peptidomimetic 51 rALLy clinical trial 51 MAGE A3 ASCI 51 Charlesson 51 preclinical efficacy 51 JAK3 51 GED Preparation Day 51 Zalypsis 51 initiated Phase Ib 51 infill submarkets 51 Shigatoxin producing E. coli 51 platforms GVAX 51 Phase IIa trials 51 Kosan motilin agonist 51 nephrology oncology supportive 51 PANVAC VF 51 hyperphenylalaninemia HPA due 51 Cephalon Oncology 51 Adenosine Therapeutics 51 aurora kinase inhibitor 51 Asthma COPD 51 autoimmune inflammatory 51 PROSTASCINT R 51 Pimavanserin 51 ZFP Therapeutic 51 Sherridon Property 51 RealPennies.com RealPennies.com 51 visit www.stopandshop.com 51 humanised antibody 51 BiTE antibodies targeting 51 Romidepsin 51 polysaccharide polymer 51 TYPE Front 51 home tna public html 51 compound perifosine 51 PRT# 51 signal transduction inhibitors 51 essential thrombocythemia ET 51 including HGF ErbB3 51 Prednisporin 51 GED aPC 51 clinical trials Archexin 51 HIV integrase 51 urocortin 2 51 Trofex ™ 51 targeting PCSK9 51 immuno therapeutic 51 androgen receptor antagonist 51 Saturn Vue Chevrolet HHR 51 Boxset Contents 51 CINOD 51 immunomodulating 51 Myocet 51 antiinfective 51 AVI BioPharma develops 51 hypoxia selective 51 UVIDEM 51 Submits NDA 51 #D# #F C 51 NNR Therapeutics 51 amide hydrolase 51 HepeX B 51 KNS # 51 infection ALN VSP 51 biodefense pathogens 51 siRNA compounds 51 Allovectin 7 51 product candidate Lpathomab 51 receptor tyrosine kinase inhibitor 51 Te tellurium based 51 Sphingomab 51 Initiate Phase 51 GLUMETZA R 51 ANAVEX #-# [002] 51 LymphoStat B TM 51 warships patroling 51 YONDELIS 51 inhaled liposomal ciprofloxacin 51 fungal infections Hepatitis C